Literature DB >> 31926053

Expanding the genotype-phenotype correlation of de novo heterozygous missense variants in YWHAG as a cause of developmental and epileptic encephalopathy.

Farah Kanani1, Hannah Titheradge2, Nicola Cooper2, Frances Elmslie3, Melissa M Lees4, Jane Juusola5, Laura Pisani6, Carolyn McKenna6, Cyril Mignot7, Stephanie Valence8, Boris Keren9, Katherine Lachlan10, Meena Balasubramanian1,11.   

Abstract

Developmental and Epileptic encephalopathies (DEE) describe heterogeneous epilepsy syndromes, characterized by early-onset, refractory seizures and developmental delay (DD). Several DEE associated genes have been reported. With increased access to whole exome sequencing (WES), new candidate genes are being identified although there are fewer large cohort papers describing the clinical phenotype in such patients. We describe 6 unreported individuals and provide updated information on an additional previously reported individual with heterozygous de novo missense variants in YWHAG. We describe a syndromal phenotype, report 5 novel, and a recurrent p.Arg132Cys YWHAG variant and compare developmental trajectory and treatment strategies in this cohort. We provide further evidence of causality in YWHAG variants. WES was performed in five patients via Deciphering Developmental Disorders Study and the remaining two were identified via Genematcher and AnnEX databases. De novo variants identified from exome data were validated using Sanger sequencing. Seven out of seven patients in the cohort have de novo, heterozygous missense variants in YWHAG including 2/7 patients with a recurrent c.394C > T, p.Arg132Cys variant; 1/7 has a second, pathogenic variant in STAG1. Characteristic features included: early-onset seizures, predominantly generalized tonic-clonic and absence type (7/7) with good response to standard anti-epileptic medications; moderate DD; Intellectual Disability (ID) (5/7) and Autism Spectrum Disorder (3/7). De novo YWHAG missense variants cause EE, characterized by early-onset epilepsy, ID and DD, supporting the hypothesis that YWHAG loss-of-function causes a neurological phenotype. Although the exact mechanism of disease resulting from alterations in YWHAG is not fully known, it is possible that haploinsufficiency of YWHAG in developing cerebral cortex may lead to abnormal neuronal migration resulting in DEE.
© 2020 Wiley Periodicals, Inc.

Entities:  

Keywords:  zzm321990YWHAG; developmental delay; early-onset seizures; epileptic encephalopathy; intellectual disability

Mesh:

Substances:

Year:  2020        PMID: 31926053     DOI: 10.1002/ajmg.a.61483

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  3 in total

1.  Genetic analysis and identification of novel variations in Chinese patients with pediatric epilepsy by whole-exome sequencing.

Authors:  Xuechao Zhao; Haofeng Ning; Yanhong Wang; Ganye Zhao; Shiyue Mei; Ning Liu; Conghui Wang; Aojie Cai; Erhu Wei; Xiangdong Kong
Journal:  Neurol Sci       Date:  2022-02-26       Impact factor: 3.307

2.  A heterozygous missense variant in the YWHAG gene causing developmental and epileptic encephalopathy 56 in a Chinese family.

Authors:  Zhi Yi; Zhenfeng Song; Jiao Xue; Chengqing Yang; Fei Li; Hua Pan; Xuan Feng; Ying Zhang; Hong Pan
Journal:  BMC Med Genomics       Date:  2022-10-15       Impact factor: 3.622

3.  A single center experience with publicly funded clinical exome sequencing for neurodevelopmental disorders or multiple congenital anomalies.

Authors:  Ben Pode-Shakked; Ortal Barel; Amihood Singer; Miriam Regev; Hana Poran; Aviva Eliyahu; Yael Finezilber; Meirav Segev; Michal Berkenstadt; Hagith Yonath; Haike Reznik-Wolf; Yael Gazit; Odelia Chorin; Gali Heimer; Lidia V Gabis; Michal Tzadok; Andreea Nissenkorn; Omer Bar-Yosef; Efrat Zohar-Dayan; Bruria Ben-Zeev; Nofar Mor; Nitzan Kol; Omri Nayshool; Noam Shimshoviz; Ifat Bar-Joseph; Dina Marek-Yagel; Elisheva Javasky; Reviva Einy; Moran Gal; Julia Grinshpun-Cohen; Mordechai Shohat; Dan Dominissini; Annick Raas-Rothschild; Gideon Rechavi; Elon Pras; Lior Greenbaum
Journal:  Sci Rep       Date:  2021-09-27       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.